Recruiting ISRCTN16838597
This study is recruiting in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
In France Schizophrenia Other Over 18 Years
Countries United States, France, United Kingdom, ...
Sponsor Dainippon Sumitomo Pharma America Inc. (USA)
Condition Schizophrenia Recruiting NCT05511363
This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
In France Schizophrenia Drug i A study involving a medication or substance. From 55 Years to 90 Years
Countries United States, France, United Kingdom, ...
Sponsor Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition Schizophrenia Recruiting NCT06887192
This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.
In France Schizophrenia Drug From 55 Years to 90 Years
Countries United States, France, Canada, ...
Sponsor MapLight Therapeutics
Condition Schizophrenia Recruiting NCT06929273
This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
In France Bipolarity Drug From 18 Years to 65 Years
Countries United States, Australia, France, ...
Sponsor Bristol-Myers Squibb
Condition Bipolarity Recruiting NCT06585787
This study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.
In France Schizophrenia Drug From 55 Years to 90 Years
Countries United States, France, Belgium, ...
Sponsor Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition Schizophrenia Recruiting NCT07140913
This study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.
In France Bipolarity Drug From 18 Years to 65 Years
Countries United States, France, Argentina, ...
Sponsor Bristol-Myers Squibb
Condition Bipolarity Recruiting NCT07424404
This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.
In France Schizophrenia Drug From 5 Years to 17 Years
Countries United States, France, Canada, ...
Sponsor Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition Schizophrenia Recruiting NCT06159673
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.
In France Schizophrenia Drug From 55 Years to 95 Years
Countries United States, France, Brazil, ...
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Recruiting NCT05964192
This study is recruiting. It focuses on depression and currently lists participation information in France.
In France Depression Other From 18 Years to 65 Years
Countries France
Sponsor Centre Hospitalier Rouffach
Condition Depression Recruiting NCT07540429
This study is recruiting. It focuses on ADHD and currently lists participation information in France.
In France ADHD Diagnostic Test i A study that looks at how to detect, measure, or better understand a condition. From 12 Years to 17 Years
Countries France
Sponsor Etablissement Public de la Sante Mentale de la Somme
Condition ADHD Recruiting NCT05632497
This study is recruiting. It focuses on depression and currently lists participation information in France.
In France Depression Biological Over 18 Years
Countries France
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Depression Recruiting NCT07642882
This study is recruiting. It focuses on depression and currently lists participation information in France.
In France Depression Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 80 Years
Countries France
Sponsor Hospital Ambroise Paré Paris
Condition Depression 
